
EX-31 2 exhibit31.htm CERT 302
EXHIBIT 31
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT
TO RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS
AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-
OXLEY ACT OF 2002
I, Nora Coccaro, chief executive officer and chief financial officer of Healthbridge, Inc., (“Registrant”) certify that:
1.     I have reviewed this Quarterly Report on Form 10-QSB (“Report”) of Registrant;
2.     Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this Report;
3.     Based on my knowledge, the financial statements, and other financial information included in this Report, fairly
present in all material respects the financial condition, results of operations and cash flows of the Registrant as of,
and for, the period presented in this Report;
4.     I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e) for the Registrant and have:
a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under my supervision, to ensure that material information relating to the Registrant, including its
consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which
this Report is being prepared;
b)     Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report
my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and
c)     Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred
during the Registrant’s most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial
reporting; and
5.     I have disclosed, based on my most recent evaluation, to the Registrant’s auditors and the audit committee of
Registrant’s board of directors (or persons performing the equivalent functions):
a)     All significant deficiencies and material weaknesses in the design or operation of internal controls over financial
reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and
report financial information; and
b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in
the Registrant’s internal controls over financial reporting.
Date: November 14, 2005
/s/ Nora Coccaro
Nora Coccaro, Chief Executive Officer and Chief Financial Officer